close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar48Point01
Implied share price

Buy Undervalued by 71.6%

5% margin of safety What's this?

EV / EBITDA
Use Average
ABC
AmerisourceBergen Corp.
DNA
Genentech, Inc.
Change
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
CELG
Celgene Corporation
Change
13.83 8.13 17.08 7.14 7.15 21.99
All amounts in millions
from last financial year
         
Implied Share Price $48.01 $77.54 $99.06 $63.31 $35.58
Market Cap 7,799 100,042 50,406 27,691 24,227
Net Debt 168 -3,369 -2,841 -495 -2,975
Enterprise Value (EV) 7,967 96,673 47,565 27,195 21,251
Revenue 71,759 13,418 14,642 7,011 2,689
EBITDA 979 5,661 6,658 3,802 966
Percent 1.4 % 42.2 % 45.5 % 54.2 % 35.9 %
EBIT 900 5,069 5,609 3,589 841
Percent 1.3 % 37.8 % 38.3 % 51.2 % 31.3 %
Balance Sheet          
Total Assets 13,572 21,787 39,629 9,698 5,389
Total Liabilities 10,856 6,116 16,962 3,331 994
Shareholders Equity 2,716 15,671 22,667 6,367 4,394.606

Price history

Comments

No comments yet. Login to comment.